Blaze Bioscience, Inc.
Seattle, WA
- UEI
- MCPAPJ82ZLF5
- CAGE
- 6J3Q5
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 530 Fairview Ave N #1400, Seattle, WA 98109, USA
- Website
- blazebioscience.com
- Founded
- 2010
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A novel tumor paint product for sarcoma resection | National Cancer Institute (NIH) | $1,499,549 | |
| Other functions - a novel tumor paint for tumor resection | National Cancer Institute (NIH) | $248,551 |
Quick answers
Is Blaze Bioscience, Inc. registered in SAM.gov?
Yes. Blaze Bioscience, Inc.'s SAM.gov registration is active through December 21, 2026.
What is Blaze Bioscience, Inc.'s most recent federal award?
Blaze Bioscience, Inc.'s most recent federal contract award is A novel tumor paint product for sarcoma resection (HHSN261201400046C), from National Cancer Institute (NIH), on September 19, 2014.
On GovTribe
See Blaze Bioscience, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors